Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CELC NASDAQ:INNV NASDAQ:LFST NYSE:PACS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCELCCelcuity$45.88+3.7%$18.60$7.57▼$48.00$1.79B0.682.58 million shs1.33 million shsINNVInnovAge$3.31+1.2%$3.87$2.60▼$6.69$446.89M0.5136,731 shs11,607 shsLFSTLifeStance Health Group$4.37+13.2%$4.77$3.74▼$8.61$1.70B1.132.47 million shs7.39 million shsPACSPACS Group$11.15+0.5%$11.83$8.28▼$43.92$1.70B0.88509,999 shs346,696 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCELCCelcuity0.00%+14.96%+236.86%+352.02%+185.86%INNVInnovAge0.00%+5.75%-21.19%-8.31%-44.28%LFSTLifeStance Health Group0.00%+15.30%-7.61%-23.73%-20.69%PACSPACS Group0.00%+4.99%-12.82%+6.60%-65.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCELCCelcuity0.5834 of 5 stars1.51.00.00.01.13.30.0INNVInnovAge1.7718 of 5 stars2.83.00.00.00.01.70.6LFSTLifeStance Health Group3.191 of 5 stars3.44.00.00.02.62.50.6PACSPACS Group3.1324 of 5 stars3.43.00.00.01.40.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCELCCelcuity 3.00Buy$39.20-14.56% DownsideINNVInnovAge 1.50Reduce$5.0051.06% UpsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5094.51% UpsidePACSPACS Group 2.86Moderate Buy$34.29207.50% UpsideCurrent Analyst Ratings BreakdownLatest INNV, PACS, CELC, and LFST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.007/28/2025CELCCelcuityLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$28.00 ➝ $60.007/28/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$27.00 ➝ $50.007/28/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.007/1/2025CELCCelcuityStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.006/30/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.005/27/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$8.505/19/2025CELCCelcuityHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$27.00 ➝ $27.005/15/2025CELCCelcuityNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $29.00(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCELCCelcuityN/AN/AN/AN/A$3.11 per shareN/AINNVInnovAge$831.68M0.54N/AN/A$2.04 per share1.62LFSTLifeStance Health Group$1.25B1.36$0.04 per share110.21$3.78 per share1.16PACSPACS Group$3.56B0.48N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCELCCelcuity-$111.78M-$3.03N/AN/AN/AN/A-96.21%-49.44%8/14/2025 (Estimated)INNVInnovAge-$21.34M-$0.23N/A55.17N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)LFSTLifeStance Health Group-$57.44M-$0.10N/AN/AN/A-1.23%-1.12%-0.77%N/APACSPACS Group$112.87MN/A0.006.26N/AN/AN/AN/A8/11/2025 (Estimated)Latest INNV, PACS, CELC, and LFST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CELCCelcuity-$0.94N/AN/AN/AN/AN/A8/11/2025Q2 2025PACSPACS Group$0.45N/AN/AN/AN/AN/A8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million5/14/2025Q1 2025CELCCelcuity-$0.95-$0.86+$0.09-$0.86N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCELCCelcuityN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/APACSPACS GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCELCCelcuity1.146.616.61INNVInnovAge0.040.780.78LFSTLifeStance Health Group0.191.471.47PACSPACS GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCELCCelcuity63.33%INNVInnovAge12.26%LFSTLifeStance Health Group85.50%PACSPACS GroupN/AInsider OwnershipCompanyInsider OwnershipCELCCelcuity15.77%INNVInnovAge1.40%LFSTLifeStance Health Group3.20%PACSPACS GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCELCCelcuity4038.91 million32.78 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionableLFSTLifeStance Health Group10,218388.88 million376.43 millionOptionablePACSPACS Group32,433152.40 millionN/AOptionableINNV, PACS, CELC, and LFST HeadlinesRecent News About These CompaniesPACS Group (PACS) to Release Earnings on MondayAugust 9 at 2:59 AM | americanbankingnews.comBo Dietl forms PAC to fight Mamdani, with help from Rudy GiulianiAugust 7 at 2:37 AM | nydailynews.comMusk-linked group spends big to promote newly enacted megabillAugust 5, 2025 | msn.comUnprecedented Big Money Surge for Super PAC Tied to TrumpAugust 5, 2025 | brennancenter.orgBBeto O’Rourke’s political group is a top funder for Texas Democrats’ exodus to block GOP congressional mapAugust 5, 2025 | msn.comPACS Group (PACS) Expected to Announce Earnings on MondayAugust 5, 2025 | marketbeat.comTrump’s super PAC has ballooned to $200M thanks to Musk and other Silicon Valley heavyweightsAugust 2, 2025 | msn.comRepublican super PACs bank millions ahead of midterm battlesAugust 2, 2025 | msn.comHow top Democrats are already gearing up for 2028 onlineAugust 2, 2025 | msn.comElon Musk group that was active in Wisconsin spent more than $47 million in the first half of the yearAugust 2, 2025 | jsonline.comJGroup run by billionaire Elon Musk spent more than $47 million in the first half of the yearAugust 2, 2025 | msn.comTrump, Term-Limited, Amasses $200 Million War Chest for Political AmbitionsAugust 1, 2025 | nytimes.comTrump’s political operation has stockpiled a massive amount of cash ahead of the midtermsAugust 1, 2025 | msn.comTrump's super PAC raises a massive $177 million, bolstering his political influenceAugust 1, 2025 | yahoo.comPAC Funded By Soros-Linked Trial Lawyers Donates $20K To Hancock CampaignJuly 31, 2025 | yahoo.comElon Musk gives millions to Republican super PACs ahead of the midtermsJuly 31, 2025 | msn.comPod Save ... Utah? PAC grown by Obama staffers’ podcast putting $20K toward unseating GOP state lawmakers.July 31, 2025 | msn.comGroups ask federal appeals court to reinstate Maine's limits on super PACsJuly 31, 2025 | mainepublic.orgM‘Anybody but Mamdani’: 5 Groups Emerge to Raise Millions in Attack FundsJuly 30, 2025 | nytimes.comExclusive: Dems propose corporate PAC banJuly 30, 2025 | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $4.24 Million Investment in PACS Group, Inc. (NYSE:PACS)July 29, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINNV, PACS, CELC, and LFST Company DescriptionsCelcuity NASDAQ:CELC$45.88 +1.64 (+3.71%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$46.78 +0.90 (+1.96%) As of 08/8/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.InnovAge NASDAQ:INNV$3.31 +0.04 (+1.22%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$3.32 +0.01 (+0.30%) As of 08/8/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.LifeStance Health Group NASDAQ:LFST$4.37 +0.51 (+13.21%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.36 0.00 (-0.11%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.PACS Group NYSE:PACS$11.15 +0.06 (+0.54%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$11.10 -0.05 (-0.45%) As of 08/8/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
